Shareholding28 Sept 2026, 02:16 pm
RPG Life Sciences: Clarus Capital Increases Stake
AI Summary
RPG Life Sciences Ltd has received a disclosure under SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011, from Clarus Capital I and its associated entities. The acquirer, along with persons acting in concert, has increased its shareholding in RPG Life Sciences. The total holding before the transaction was 6.81%, and after the acquisition, it stands at 7.04%. This represents a net increase of 0.23% in shareholding. The acquisition was made through open market purchases, with the latest transaction on September 25, 2026, involving the purchase of 37,463 shares.
Key Highlights
- Clarus Capital I, Others acquired shares in RPG Life Sciences Ltd.
- Total shareholding increased from 6.81% to 7.04%.
- Net increase in shareholding is 0.23%.
- Acquisition was made via open market purchases.
- Disclosure filed under SEBI (SAST) Regulations, 2011.
Price Impact
More from RPGLIFE